BRCA1-associated-protein-1 inactivated melanocytic tumours: characterisation of the clinicopathological spectrum and immunohistochemical expression pattern of preferentially expressed antigen in melanoma.

Yitong XuAlejandro A Gru Thomas Brenn Katharina Wiedemeyer

Published in: Histopathology (2024)

BIMT are more common in a sporadic setting and behave indolently, despite worrying cytological atypia. PRAME immunohistochemistry is a reassuring tool in distinguishing BIMT from melanoma.

Keyphrases

poor prognosis
skin cancer
late onset
long non coding rna
early onset